Literature DB >> 35798926

Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis.

Galina Kolesova1, Alexander Stepanov2, Galina Lebedeva3, Oleg Demin2,3.   

Abstract

In a standard situation, a quantitative systems pharmacology model describes a "reference patient," and the model parameters are fixed values allowing only the mean values to be described. However, the results of clinical trials include a description of variability in patients' responses to a drug, which is typically expressed in terms of conventional statistical parameters, such as standard deviations (SDs) from mean values. Therefore, in this study, we propose and compare four different approaches: (1) Monte Carlo Markov Chain (MCMC); (2) model fitting to Monte Carlo sample; (3) population of clones; (4) stochastically bounded selection to generate virtual patient populations based on experimentally measured mean data and SDs. We applied these approaches to generate virtual patient populations in the QSP model of erythropoiesis. According to the results of our research, stochastically bounded selection showed slightly better results than the other three methods as it allowed the description of any number of patients from clinical trials and could be applied in the case of complex models with a large number of variable parameters.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Distribution; Fitting; Mean; Quantitative systems pharmacology; Standard deviation; Virtual patients population

Year:  2022        PMID: 35798926     DOI: 10.1007/s10928-022-09814-y

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.410


  4 in total

Review 1.  Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation.

Authors:  Jenny Y Chien; Stuart Friedrich; Michael A Heathman; Dinesh P de Alwis; Vikram Sinha
Journal:  AAPS J       Date:  2005-10-07       Impact factor: 4.009

2.  A Flavonoid Glycoside Compound from Murraya paniculata (L.) Interrupts Metastatic Characteristics of A549 Cells by Regulating STAT3/NF-κB/COX-2 and EGFR Signaling Pathways.

Authors:  Qing Shi; Zhou Jiang; Jingyi Yang; Yunlong Cheng; Yaqiong Pang; Ning Zheng; Jiahang Chen; Wenge Chen; Lee Jia
Journal:  AAPS J       Date:  2017-08-25       Impact factor: 4.009

3.  Improving the generation and selection of virtual populations in quantitative systems pharmacology models.

Authors:  Theodore R Rieger; Richard J Allen; Lukas Bystricky; Yuzhou Chen; Glen Wright Colopy; Yifan Cui; Angelica Gonzalez; Yifei Liu; R D White; R A Everett; H T Banks; Cynthia J Musante
Journal:  Prog Biophys Mol Biol       Date:  2018-06-15       Impact factor: 3.667

4.  A Quantitative Systems Pharmacology Model for the Key Interleukins Involved in Crohn's Disease.

Authors:  Violeta Balbas-Martinez; Eduardo Asin-Prieto; Zinnia P Parra-Guillen; Iñaki F Troconiz
Journal:  J Pharmacol Exp Ther       Date:  2019-12-10       Impact factor: 4.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.